FIELD: medicine.
SUBSTANCE: neovasculgen 1.2 mg is introduced intramuscularly two weeks and one day before a revascularisation surgery.
EFFECT: method enables optimising the regress of lower extremity regression in the patients with arteriosclerosis obliterans ensured by improving the peripheral blood flow and maintaining the bypass patency.
1 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED METHOD OF TREATMENT OF PATIENTS WITH CRITICAL ISCHEMIA OF LOWER EXTREMITIES | 2023 |
|
RU2808920C1 |
METHOD OF COMBINED SURGICAL STIMULATION OF LOWER EXTREMITY CHRONIC LOWER LIMB NEOANGIOGENESIS | 2018 |
|
RU2703395C1 |
METHOD OF TREATING OBLITERATING ATHEROSCLEROSIS OF LOWER LIMB ARTERIES | 2008 |
|
RU2368344C1 |
METHOD OF TREATING CHRONIC ISCHEMIA OF LOWER EXTREMITIES OF ATHEROSCLEROTIC GENESIS IN FEMORAL AND POPLITEAL ARTERIES OCCLUSION | 2018 |
|
RU2691654C1 |
COMBINED METHOD OF TREATMENT OF PATIENTS WITH CRITICAL ISCHEMIA OF THE LOWER EXTREMITIES | 2023 |
|
RU2796189C1 |
METHOD FOR PREVENTING THROMBOTIC COMPLICATIONS AFTER RECONSTRUCTIVE VASCULAR SURGICAL INTERFERENCES | 2004 |
|
RU2308227C2 |
METHOD OF SURGICAL MANAGEMENT OF CHRONIC CRITICAL ISCHEMIA OF LOWER EXTREMITIES IN DIABETIC PATIENTS | 2008 |
|
RU2403879C2 |
METHOD FOR EVALUATING THE EFFICIENCY OF VASCULAR RECONSTRUCTION IN PATIENTS WITH CRITICAL ISCHEMIA OF INFERIOR LIMBS | 2006 |
|
RU2310376C1 |
METHOD OF DIAGNOSING CHRONIC OCCLUSION OF FEMORAL ARTERY IN HUNTER'S CANAL | 1992 |
|
RU2085110C1 |
METHOD OF TREATING REPERFUSION SYNDROME IN PATIENTS WITH DIABETES MELLITUS FOLLOWING RE-VASCULARISATION OF LOWER EXTREMITY ARTERIES | 2014 |
|
RU2548739C1 |
Authors
Dates
2014-01-27—Published
2012-12-04—Filed